×
About 4,265 results

ALLMedicine™ Arteriovenous Malformations Center

Research & Reviews  1,601 results

A case of capillary malformation-arteriovenous malformation and Ebstein's anomaly in a ...
https://doi.org/10.1111/pde.14723
Pediatric Dermatology; Sherwani Y, Jenkins S et. al.

Aug 3rd, 2021 - Capillary malformation-arteriovenous malformation (CM-AVM) is a rare condition characterized by multiple cutaneous capillary malformations with potential associated arteriovenous malformations. RAS p21 protein activator 1 (RASA1) and ephrin type-B...

Current concepts and perspectives on brain arteriovenous malformations: A review of pat...
https://doi.org/10.1016/j.wneu.2021.07.106
World Neurosurgery; Sugiyama T, Grasso G et. al.

Aug 3rd, 2021 - Brain arteriovenous malformations (bAVMs) are unusual vascular pathologies characterized by the abnormal aggregation of dilated arteries and veins in the brain parenchyma and for which the absence of a normal vascular structure and capillary bed l...

Effect of Prior Embolization on Outcomes After Stereotactic Radiosurgery for Pediatric ...
https://doi.org/10.1093/neuros/nyab245
Neurosurgery Burke RM, Chen CJ et. al.

Aug 2nd, 2021 - Pediatric brain arteriovenous malformations (AVMs) are a significant cause of morbidity but the role of multimodal therapy in the treatment of these lesions is not well understood. To compare the outcomes of stereotactic radiosurgery (SRS) with an...

Chronic encapsulated expanding hematomas after stereotactic radiosurgery for intracrani...
https://doi.org/10.3171/2021.1.JNS203476
Journal of Neurosurgery; Abou-Al-Shaar H, Faramand A et. al.

Jul 31st, 2021 - Cerebral arteriovenous malformations (AVMs) are rare cerebral vascular lesions that are associated with high morbidity and mortality from hemorrhage; however, stereotactic radiosurgery (SRS) is a well-validated treatment modality. Few reports have...

The Irradiated Brain Volume Within 12 Gy Is a Predictor for Radiation-Induced Changes A...
https://doi.org/10.1016/j.ijrobp.2021.05.135
International Journal of Radiation Oncology, Biology, Phy... Yang HC, Wu HM et. al.

Jul 26th, 2021 - Our purpose was to determine whether the coverage of brain parenchyma within the 12 Gy radiosurgical volume (V12) correlates with the development of radiation-induced changes (RICs) in patients with unruptured cerebral arteriovenous malformations ...

see more →

Guidelines  1 results

International guidelines for the diagnosis and management of hereditary haemorrhagic te...
https://doi.org/10.1136/jmg.2009.069013
Journal of Medical Genetics; Faughnan ME, Palda VA et. al.

Jun 26th, 2009 - HHT is an autosomal dominant disease with an estimated prevalence of at least 1/5000 which can frequently be complicated by the presence of clinically significant arteriovenous malformations in the brain, lung, gastrointestinal tract and liver. HH...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  37 results

Transvenous Approach for the Treatment of Cerebral Arteriovenous Malformations
https://clinicaltrials.gov/ct2/show/NCT03691870

Apr 17th, 2020 - A new endovascular route for the treatment of brain AVMs may be possible in some cases: Trans-Venous Embolization (TVE). The technique uses microcatheters to navigate to the draining veins of AVM, to reach and then fill the AVM nidus retrogradely ...

Surgical Management of Cerebral Arteriovenous Malformations Within Hybrid Operation Room
https://clinicaltrials.gov/ct2/show/NCT03209804

Mar 13th, 2020 - Purpose: Have an evaluation of clinical benefits and risks of hybrid operating techniques in management of cerebral arteriovenous malformations(AVMs). Meanwhile, as a new cooperative interventional modality, optimized workflows, technical key knot...

Biology of Cerebral Arteriovenous Malformations and Prognosis of Cerebral Arteriovenous Malformations
https://clinicaltrials.gov/ct2/show/NCT03676868

Feb 25th, 2020 - The cerebral arteriovenous malformations correspond to the formation of an entanglement of morphologically abnormal vessels called nidus, which shunt the blood circulation directly from the arterial circulation to the venous circulation. The cereb...

BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT).
https://clinicaltrials.gov/ct2/show/NCT03227263

Dec 19th, 2019 - The recognized manifestations of HHT are all due to abnormalities of vascular structure. Epistaxis and digestive arteriovenous malformations may be responsible for severe hemorrhages in 5% of HHT patients, requiring repeated blood transfusions and...

PHIL Evaluation in the Endovascular Treatment of Intracranial Dural AVF
https://clinicaltrials.gov/ct2/show/NCT03317821

Dec 4th, 2019 - This is an European multi-center observational study. Treatments and follow-up visits will be done as per standard of care. The objective of this study is to evaluate the efficacy and safety of the PHIL® device in the treatment of intracranial dur...

see more →

News  52 results

Skill Checkup: An Electrical Conundrum
https://reference.medscape.com/viewarticle/952644

Jun 11th, 2021 - The Skill Checkup series provides a quick, case-style interactive quiz highlighting key guidelines- and evidence-based information to inform clinical practice. A 76-year-old man presented with syncope preceded by prolonged dizziness. His medical h...

New Guidelines Expand Management Options for Hereditary Hemorrhagic Telangiectasia
https://www.staging.medscape.com/viewarticle/937096

Sep 10th, 2020 - NEW YORK (Reuters Health) - New guidelines provide updated advice on managing epistaxis and vascular malformations and new recommendations for managing gastrointestinal (GI) bleeding, anemia, pediatric care, and pregnancy and delivery. The expert ...

LVAD-Related GI Bleeding: Another Reason to Take Heart Failure Drugs
https://www.medpagetoday.com/cardiology/chf/79091

Apr 8th, 2019 - Angiotensin II antagonists may help prevent GI bleeding among heart failure patients with continuous-flow left ventricular assist devices (LVADs), a retrospective study suggested. Taking ACE inhibitors or angiotensin receptor blockers (ARBs) at an...

Medtronic in $31 Million Settlement With DOJ Over Medical Devices
https://www.medscape.com/viewarticle/906114

Dec 6th, 2018 - Two companies now owned by Medtronic have agreed to pay a total of $31 million to resolve US Department of Justice (DOJ) charges involving marketing violations and kickback schemes. Medical device maker ev3 has agreed to plead guilty to charges re...

Medtronic in $31 Million Settlement With DOJ Over Medical Devices
https://www.staging.medscape.com/viewarticle/906114

Dec 6th, 2018 - Two companies now owned by Medtronic have agreed to pay a total of $31 million to resolve US Department of Justice (DOJ) charges involving marketing violations and kickback schemes. Medical device maker ev3 has agreed to plead guilty to charges re...

see more →

Patient Education  12 results see all →